Evaluation of selected features of Staphylococcus cohnii enabling colonization of humans
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu hodnotící studie, časopisecké články, práce podpořená grantem
PubMed
12503405
DOI
10.1007/bf02818799
Knihovny.cz E-zdroje
- MeSH
- antibakteriální látky farmakologie MeSH
- bakteriologické techniky MeSH
- endopeptidasy metabolismus MeSH
- jednotky intenzivní péče * MeSH
- kojenec MeSH
- kůže chemie mikrobiologie MeSH
- lidé MeSH
- lipasa metabolismus MeSH
- mastné kyseliny farmakologie MeSH
- mikrobiální testy citlivosti MeSH
- stafylokokové infekce mikrobiologie MeSH
- Staphylococcus účinky léků růst a vývoj metabolismus MeSH
- železo metabolismus MeSH
- životní prostředí * MeSH
- Check Tag
- kojenec MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antibakteriální látky MeSH
- endopeptidasy MeSH
- lipasa MeSH
- mastné kyseliny MeSH
- železo MeSH
Based on iron utilization, sensitivity to skin fatty acids, lipolytic and proteolytic activity the potential abilities of Staphylococcus cohnii strains to colonize humans were evaluated. The investigation included 60 strains that belong to both subspecies, viz. S. cohnii ssp. cohnii and S. cohnii ssp. urealyticus. Strains were isolated from different sources of the Intensive Care Unit and from non-hospital environment. Most of the strains were multiple antibiotic-resistant. Strains of both subspecies revealed a relatively low iron requirement. These strains were capable of utilizing iron bound in oxo acids and from host iron-binding proteins. S. cohnii ssp. urealyticus were more effective in iron uptake than S. cohnii ssp. cohnii. All investigated strains revealed sensitivity to skin fatty acids, but S. cohnii ssp. urealyticus strains were more resistant. Special features of strains of this subspecies promote colonization of humans.
Zobrazit více v PubMed
Eur J Clin Microbiol Infect Dis. 1995 Oct;14(10):904-8 PubMed
J Med Microbiol. 1995 Jul;43(1):26-32 PubMed
J Hosp Infect. 1996 Mar;32(3):217-27 PubMed
J Hosp Infect. 2000 Jun;45(2):145-54 PubMed
Med Dosw Mikrobiol. 1997;49(1-2):45-53 PubMed
Infect Immun. 1981 Aug;33(2):555-64 PubMed
FEMS Microbiol Lett. 1989 Nov;53(1-2):123-7 PubMed
J Bacteriol. 1993 May;175(9):2727-33 PubMed
Infect Immun. 1988 Apr;56(4):721-5 PubMed
J Med Microbiol. 1981 Feb;14(1):41-9 PubMed
J Am Acad Dermatol. 1986 Feb;14(2 Pt 1):221-5 PubMed
Appl Environ Microbiol. 1992 Feb;58(2):624-9 PubMed
Int J Syst Bacteriol. 1999 Apr;49 Pt 2:489-502 PubMed
J Gen Microbiol. 1976 Jun;94(2):290-6 PubMed
Antonie Van Leeuwenhoek. 1978;44(3-4):257-67 PubMed
Antimicrob Agents Chemother. 1996 Feb;40(2):302-6 PubMed
Eur J Clin Microbiol Infect Dis. 1999 Jul;18(7):530 PubMed
FEMS Microbiol Rev. 1993 Nov;12(4):325-48 PubMed
J Med Microbiol. 1992 Oct;37(4):232-4 PubMed
Acta Microbiol Pol. 2000;49(2):121-33 PubMed
Cohabitation--relationships of corynebacteria and staphylococci on human skin
Staphylococcus cohnii hemolysins - isolation, purification and properties
Molecular diagnostics of clinically important staphylococci
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit
Aggregation of Lactobacilli and Bifidobacteria with Escherichia coli O157
Potential virulence-associated properties of Plesiomonas shigelloides strains
